Our study tried to resolve some rather controversial aspects of the PTX use as a biomarker of disease activity in SLE but despite several studies, the literature provides a contradictory picture of PTX3 in SLE patients and several questions should be answered. The gene discussed is PTX3; the disease is systemic lupus erythematosus.